These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

146 related items for PubMed ID: 14648709

  • 1. High levels of circulating testosterone are not associated with increased prostate cancer risk: a pooled prospective study.
    Stattin P, Lumme S, Tenkanen L, Alfthan H, Jellum E, Hallmans G, Thoresen S, Hakulinen T, Luostarinen T, Lehtinen M, Dillner J, Stenman UH, Hakama M.
    Int J Cancer; 2004 Jan 20; 108(3):418-24. PubMed ID: 14648709
    [Abstract] [Full Text] [Related]

  • 2. Prospective study of sex hormone levels and risk of prostate cancer.
    Gann PH, Hennekens CH, Ma J, Longcope C, Stampfer MJ.
    J Natl Cancer Inst; 1996 Aug 21; 88(16):1118-26. PubMed ID: 8757191
    [Abstract] [Full Text] [Related]

  • 3. Androgens and prostate cancer risk: a prospective study.
    Wirén S, Stocks T, Rinaldi S, Hallmans G, Bergh A, Stenman UH, Kaaks R, Stattin P.
    Prostate; 2007 Aug 01; 67(11):1230-7. PubMed ID: 17562541
    [Abstract] [Full Text] [Related]

  • 4. Circulating steroid hormones and the risk of prostate cancer.
    Severi G, Morris HA, MacInnis RJ, English DR, Tilley W, Hopper JL, Boyle P, Giles GG.
    Cancer Epidemiol Biomarkers Prev; 2006 Jan 01; 15(1):86-91. PubMed ID: 16434592
    [Abstract] [Full Text] [Related]

  • 5. Endogenous sex hormones and the risk of prostate cancer: a prospective study.
    Weiss JM, Huang WY, Rinaldi S, Fears TR, Chatterjee N, Hsing AW, Crawford ED, Andriole GL, Kaaks R, Hayes RB.
    Int J Cancer; 2008 May 15; 122(10):2345-50. PubMed ID: 18172860
    [Abstract] [Full Text] [Related]

  • 6. Sex steroid hormones and the androgen receptor gene CAG repeat and subsequent risk of prostate cancer in the prostate-specific antigen era.
    Platz EA, Leitzmann MF, Rifai N, Kantoff PW, Chen YC, Stampfer MJ, Willett WC, Giovannucci E.
    Cancer Epidemiol Biomarkers Prev; 2005 May 15; 14(5):1262-9. PubMed ID: 15894683
    [Abstract] [Full Text] [Related]

  • 7. Androgens in serum and the risk of prostate cancer: a nested case-control study from the Janus serum bank in Norway.
    Vatten LJ, Ursin G, Ross RK, Stanczyk FZ, Lobo RA, Harvei S, Jellum E.
    Cancer Epidemiol Biomarkers Prev; 1997 Nov 15; 6(11):967-9. PubMed ID: 9367072
    [Abstract] [Full Text] [Related]

  • 8. Endogenous sex hormones and prostate cancer risk: a case-control study nested within the Carotene and Retinol Efficacy Trial.
    Chen C, Weiss NS, Stanczyk FZ, Lewis SK, DiTommaso D, Etzioni R, Barnett MJ, Goodman GE.
    Cancer Epidemiol Biomarkers Prev; 2003 Dec 15; 12(12):1410-6. PubMed ID: 14693730
    [Abstract] [Full Text] [Related]

  • 9. Serum androgens and prostate cancer among 643 cases and 643 controls in the European Prospective Investigation into Cancer and Nutrition.
    Travis RC, Key TJ, Allen NE, Appleby PN, Roddam AW, Rinaldi S, Egevad L, Gann PH, Rohrmann S, Linseisen J, Pischon T, Boeing H, Johnsen NF, Tjønneland A, Overvad K, Kiemeney L, Bueno-de-Mesquita HB, Bingham S, Khaw KT, Tumino R, Sieri S, Vineis P, Palli D, Quirós JR, Ardanaz E, Chirlaque MD, Larrañaga N, Gonzalez C, Sanchez MJ, Trichopoulou A, Bikou C, Trichopoulos D, Stattin P, Jenab M, Ferrari P, Slimani N, Riboli E, Kaaks R.
    Int J Cancer; 2007 Sep 15; 121(6):1331-8. PubMed ID: 17514649
    [Abstract] [Full Text] [Related]

  • 10. Higher sex hormone-binding globulin and lower bioavailable testosterone are related to prostate cancer detection on prostate biopsy.
    García-Cruz E, Carrión Puig A, García-Larrosa A, Sallent A, Castañeda-Argáiz R, Piqueras M, Ribal MJ, Leibar-Tamayo A, Romero-Otero J, Alcaraz A.
    Scand J Urol; 2013 Aug 15; 47(4):282-9. PubMed ID: 23181478
    [Abstract] [Full Text] [Related]

  • 11. Serum androgens and prostate cancer risk: results from the placebo arm of the Prostate Cancer Prevention Trial.
    Schenk JM, Till C, Hsing AW, Stanczyk FZ, Gong Z, Neuhouser ML, Reichardt JK, Hoque AM, Figg WD, Goodman PJ, Tangen CM, Thompson IM.
    Cancer Causes Control; 2016 Feb 15; 27(2):175-82. PubMed ID: 26589415
    [Abstract] [Full Text] [Related]

  • 12. Plasma testosterone and sex hormone-binding globulin concentrations and the risk of prostate cancer among Japanese men: a nested case-control study.
    Sawada N, Iwasaki M, Inoue M, Sasazuki S, Yamaji T, Shimazu T, Tsugane S, Japan Public Health Center-based Prospective Study Group.
    Cancer Sci; 2010 Dec 15; 101(12):2652-7. PubMed ID: 20942896
    [Abstract] [Full Text] [Related]

  • 13. Serum sex steroids in premenopausal women and breast cancer risk within the European Prospective Investigation into Cancer and Nutrition (EPIC).
    Kaaks R, Berrino F, Key T, Rinaldi S, Dossus L, Biessy C, Secreto G, Amiano P, Bingham S, Boeing H, Bueno de Mesquita HB, Chang-Claude J, Clavel-Chapelon F, Fournier A, van Gils CH, Gonzalez CA, Gurrea AB, Critselis E, Khaw KT, Krogh V, Lahmann PH, Nagel G, Olsen A, Onland-Moret NC, Overvad K, Palli D, Panico S, Peeters P, Quirós JR, Roddam A, Thiebaut A, Tjønneland A, Chirlaque MD, Trichopoulou A, Trichopoulos D, Tumino R, Vineis P, Norat T, Ferrari P, Slimani N, Riboli E.
    J Natl Cancer Inst; 2005 May 18; 97(10):755-65. PubMed ID: 15900045
    [Abstract] [Full Text] [Related]

  • 14. Reduced circulating androgen bioactivity in patients with prostate cancer.
    Raivio T, Santti H, Schatzl G, Gsur A, Haidinger G, Palvimo JJ, Jänne OA, Madersbacher S.
    Prostate; 2003 May 15; 55(3):194-8. PubMed ID: 12692785
    [Abstract] [Full Text] [Related]

  • 15. Serum androgens and sex hormone-binding globulins in relation to lifestyle factors in older African-American, white, and Asian men in the United States and Canada.
    Wu AH, Whittemore AS, Kolonel LN, John EM, Gallagher RP, West DW, Hankin J, Teh CZ, Dreon DM, Paffenbarger RS.
    Cancer Epidemiol Biomarkers Prev; 1995 May 15; 4(7):735-41. PubMed ID: 8672990
    [Abstract] [Full Text] [Related]

  • 16. Prostate cancer risk in testosterone-treated men.
    Raynaud JP.
    J Steroid Biochem Mol Biol; 2006 Dec 15; 102(1-5):261-6. PubMed ID: 17113983
    [Abstract] [Full Text] [Related]

  • 17. Hormonal profile of diabetic men and the potential link to prostate cancer.
    Kasper JS, Liu Y, Pollak MN, Rifai N, Giovannucci E.
    Cancer Causes Control; 2008 Sep 15; 19(7):703-10. PubMed ID: 18340542
    [Abstract] [Full Text] [Related]

  • 18. Hormonal predictors of prostate cancer.
    Sofikerim M, Eskicorapci S, Oruç O, Ozen H.
    Urol Int; 2007 Sep 15; 79(1):13-8. PubMed ID: 17627161
    [Abstract] [Full Text] [Related]

  • 19. Sex hormone-binding globulin is a significant predictor of extracapsular extension in men undergoing radical prostatectomy.
    Salonia A, Gallina A, Briganti A, Zanni G, Suardi N, Capitanio U, Colombo R, Bertini R, Freschi M, Guazzoni G, Rigatti P, Montorsi F.
    BJU Int; 2011 Apr 15; 107(8):1243-9. PubMed ID: 20883480
    [Abstract] [Full Text] [Related]

  • 20. Serum sex steroids depict a nonlinear u-shaped association with high-risk prostate cancer at radical prostatectomy.
    Salonia A, Abdollah F, Capitanio U, Suardi N, Briganti A, Gallina A, Colombo R, Ferrari M, Castagna G, Rigatti P, Montorsi F.
    Clin Cancer Res; 2012 Jul 01; 18(13):3648-57. PubMed ID: 22589393
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.